Show simple item record

dc.contributor.authorFricke, Lara Marleen
dc.contributor.authorGlöckner, Stephan
dc.contributor.authorDreier, Maren
dc.contributor.authorLange, Berit
dc.date.accessioned2021-01-06T15:21:46Z
dc.date.available2021-01-06T15:21:46Z
dc.date.issued2020-12-03
dc.identifier.citationJ Infect. 2020 Dec 3:S0163-4453(20)30756-8. doi: 10.1016/j.jinf.2020.11.039. Epub ahead of print.en_US
dc.identifier.pmid33278399
dc.identifier.doi10.1016/j.jinf.2020.11.039
dc.identifier.urihttp://hdl.handle.net/10033/622663
dc.description.abstractObjectives: To better understand the impact of comprehensive COVID-19 targeted non-pharmaceutical interventions (NPIs) on influenza burden worldwide. Methods: We conducted a systematic literature search in selected databases (PubMed, WHO COVID-19), preprint servers (medRxiv, bioRxiv) and websites of European Public Health institutes. Documents that compared influenza estimates in the 2019/2020 season with previous seasons were included. Information synthesis was qualitative due to a high heterogeneity in the number and periods of comparative seasons, outcome measures and statistical methods. Results: We included 23 records reporting from 15 countries/regions as well as 8 reports from European Public Health agencies. Estimates in the 2019/2020 season based on influenza virus tests (4 out of 7 countries/regions), defined influenza cases (8 out of 9), influenza positivity rate (7 out of 8), and severe complications (1 out of 2) were lower than in former seasons. Results from syndromic indicators, such as influenza-like-illness (ILI), were less clear or even raised (4 out of 7) after the influenza season indicating a misclassification with COVID-19 cases. Conclusions: Evidence synthesis suggests that NPIs targeted at SARS-CoV-2-transmission reduce influenza burden as well. Low threshold NPIs need to be more strongly emphasized in influenza prevention strategies. Keywords: COVID-19; Flu; Influenza; Non-pharmaceutical interventions; SARS-CoV-2; Surveillance; Systematic review.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/101003480en_US
dc.rightsopenAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19en_US
dc.subjectFluen_US
dc.subjectInfluenzaen_US
dc.subjectNon-pharmaceutical interventionsen_US
dc.subjectSARS-CoV-2en_US
dc.subjectSurveillanceen_US
dc.subjectSystematic reviewen_US
dc.titleImpact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review.en_US
dc.typeArticleen_US
dc.identifier.eissn1532-2742
dc.contributor.departmentHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.en_US
dc.identifier.journalThe Journal of infectionen_US
refterms.dateFOA2021-01-06T15:21:47Z
dc.source.journaltitleThe Journal of infection
dc.source.countryEngland


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
Fricke. Glöckner, Dreier and ...
Size:
990.1Kb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record

openAccess
Except where otherwise noted, this item's license is described as openAccess